Investigating the efficacy and safety of platelet rich plasma in treating hair loss of patients with lichen planopilaris

Phase 3

• Conditions: Scalp hair lichen planopilaris.; Other lichen planus; L43.8

• Registration Number: IRCT20221018056229N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

Age: 18 years old and more
Definite and resistant hair loss due to LPP
The patient gives informed consent
The patient can participate in regular follow up meetings
The patient does not have serious internal disease
The patient does not have cutaneous disease in the site of treatment

Exclusion Criteria

History of any remedies taken in last month
Positive history of liver, kidney, pulmonary, cardiac, and intestinal disease and malignancies
Taking any medications for any disease which makes drug reactions possible
Accompanying of LPP with generalized lichen planus or erosive mucosal form
Other forms of noncicatricial or other forms of cicatricial alopecia except LPP

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of scalp pruritus based on LPPI. Timepoint: Investigating of scalp hair situation with using dermatoscope, at the first visit, at 1 month and 2 months and then 6 months after the first visit. Method of measurement: Dermatoscopy with dermatoscope.;The amount of scalp erythema based on LPPI. Timepoint: Investigating of scalp hair situation with using dermatoscope, at the first visit, at 1 month and 2 months and then 6 months after the first visit. Method of measurement: Dermatoscopy with dermatoscope.;The amount of scalp scaling based on LPPI. Timepoint: Investigating of scalp hair situation with using dermatoscope, at the first visit, at 1 month and 2 months and then 6 months after the first visit. Method of measurement: Dermatoscopy with dermatoscope.